Bio-Path Holdings Inc.

(BPTH) Trade

By |

Profile

Bio-Path Holdings Inc is a clinical and preclinical stage oncology focused antisense drug development company utilizing novel technology achieving systemic delivery for specific protein inhibition for any gene product that is over-expressed in disease.

Contact Information

Website: www.biopathholdings.com
Email: dmorris@biopathholdings.com
Main Phone: +1 832 742-1357
Address: 4710 Bellaire Boulevard
Address 2: Suite 210
State: TX
City / Town: Bellaire
Country: USA
Postal Code: 77401

Issuer Information

Exchange: NSC
CEO: Peter H. Nielsen
Employees: 9
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.63 $ -0.335 (-34.90%)
Last Price 0.63 Change $ -0.335 Change % -34.90 Tick N/A
Bid 0.62 Bid Size 100.00 Ask 0.63 Ask Size 300.00
Open 0.70 High 0.70 Low 0.58 Prev Close 0.96
Last Trade Volume 165,781 52 Wk Hi 5.85 52 Wk Low 0.89
Market Cap 7.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 11,340,756.00 EPS (TTM) -0.72 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 5 7
Number of Buys 5 7
Number of Sells 0 0
Net Activity 207500 257500
Last 10 Buys Shares
Michael J. Garrison 1,000
Michael J. Garrison 1,000
Michael J. Garrison 1,000
Michael J. Garrison 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 20 20 20 20
Low Target Price Estimate 20 20 20 20
Mean Target Price Estimate 20 20 20 20
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 11/13/17 11/13/17 11/13/17 11/13/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1